Category: Archived-Blog Posts

Our firm is proud to announce our participation as a sponsor at this year's TechCrunch Disrupt 2011 in San Francisco. The event will draw top high tech thought leaders to discuss entrepreneurship and industry, as well as startup companies hoping to raise venture capital. For two...

ASSOCIATION FOR MOLECULAR PATHOLOGY V. MYRIAD GENETICS (Fed. Cir. 2011): Claims directed to comparing or analyzing gene sequences should include one or more transformative steps as part of the claim. by Brian Bathurst and Leah Molera On July 29, 2011, the Court of Appeals for the Federal Circuit...

Carr & Ferrell is thrilled to congratulate Recommind, who announced this week that the USPTO had awarded the company a patent for the Workflow and Technology for Computer-Assisted Document Analysis and Review. The patent— No. 7,933,859 —gives Recommind, its customers and its partners exclusive rights to use, host...

Are you an independent inventor? Do you have a great new idea or invention, but aren’t sure how to move it to market? Do you want to sell your idea to someone with the resources to manufacture and distribute your idea, and earn...

Carr & Ferrell announced today that it is scheduled to exhibit at the Web 2.0 Expo March 29- 30 at the Moscone Center in San Francisco, California. The conference—whose 2011 theme is “Unlock the Digital Economy”—will showcase next-generation business models, development paradigms, products, and design strategies. Cofounder and Chair of Carr & Ferrell’s...

"Should I patent my invention outside of the United States?"  As a patent attorney, this is one of the questions I get asked the most by clients. While each of their situations is different, most of the time my advice to them is the same. Let's explore the issue.

A Carr & Ferrell attorney gave a guest presentation on AMP v. Myriad at Professor Larry Lasky’s Entrepreneurship in Biotechnology class at UC Berkeley’s Haas School of Business.  The presentation included an overview of the case, and explored how this ruling could impact the future of gene patents. Last...

If you’re in independent inventor, you may be interested in licensing your IP to a large corporation.  And why not? The larger the licensee, the greater the production and distribution of your product, the greater your royalty check.  Cha-ching. In a previous post, we weighed some of the pros...